BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 25279501)

  • 1. Increased prevalence of the GCM2 polymorphism, Y282D, in primary hyperparathyroidism: analysis of three Italian cohorts.
    D'Agruma L; Coco M; Guarnieri V; Battista C; Canaff L; Salcuni AS; Corbetta S; Cetani F; Minisola S; Chiodini I; Eller-Vainicher C; Spada A; Marcocci C; Guglielmi G; Zini M; Clemente R; Wong BY; de Martino D; Scillitani A; Hendy GN; Cole DE
    J Clin Endocrinol Metab; 2014 Dec; 99(12):E2794-8. PubMed ID: 25279501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of Activating GCM2 Sequence Variants in Sporadic Parathyroid Adenomas.
    Riccardi A; Aspir T; Shen L; Kuo CL; Brown TC; Korah R; Murtha TD; Bellizzi J; Parham K; Carling T; Costa-Guda J; Arnold A
    J Clin Endocrinol Metab; 2019 Jun; 104(6):1948-1952. PubMed ID: 30624640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specifying the molecular pattern of sporadic parathyroid tumorigenesis-The Y282D variant of the GCM2 gene.
    Marchiori E; Pelizzo MR; Herten M; Townsend DM; Rubello D; Boschin IM
    Biomed Pharmacother; 2017 Aug; 92():843-848. PubMed ID: 28609842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GCM2 Variants in Familial and Multiglandular Primary Hyperparathyroidism.
    Vincze S; Peters NV; Kuo CL; Brown TC; Korah R; Murtha TD; Bellizzi J; Riccardi A; Parham K; Carling T; Costa-Guda J; Arnold A
    J Clin Endocrinol Metab; 2022 Apr; 107(5):e2021-e2026. PubMed ID: 34967908
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Szalat A; Shpitzen S; Pollack R; Mazeh H; Durst R; Meiner V
    Front Endocrinol (Lausanne); 2023; 14():1254156. PubMed ID: 38130397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Glial Cells Missing-2 (GCM2) variants in parathyroid disorders.
    Canaff L; Guarnieri V; Kim Y; Wong BYL; Nolin-Lapalme A; Cole DEC; Minisola S; Eller-Vainicher C; Cetani F; Repaci A; Turchetti D; Corbetta S; Scillitani A; Goltzman D
    Eur J Endocrinol; 2022 Feb; 186(3):351-366. PubMed ID: 35038313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GCM2-Activating Mutations in Familial Isolated Hyperparathyroidism.
    Guan B; Welch JM; Sapp JC; Ling H; Li Y; Johnston JJ; Kebebew E; Biesecker LG; Simonds WF; Marx SJ; Agarwal SK
    Am J Hum Genet; 2016 Nov; 99(5):1034-1044. PubMed ID: 27745835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germline GCM2 Mutation Screening in Chinese Primary Hyperparathyroidism Patients.
    Song A; Yang Y; Wang Y; Liu S; Nie M; Jiang Y; Li M; Xia W; Wang O; Xing X
    Endocr Pract; 2020 Oct; 26(10):1093-1104. PubMed ID: 33471711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the GCM2 gene in isolated hypoparathyroidism: a molecular and biochemical study.
    Maret A; Ding C; Kornfield SL; Levine MA
    J Clin Endocrinol Metab; 2008 Apr; 93(4):1426-32. PubMed ID: 18182452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glial cells missing-2 (GCM2) transactivates the calcium-sensing receptor gene: effect of a dominant-negative GCM2 mutant associated with autosomal dominant hypoparathyroidism.
    Canaff L; Zhou X; Mosesova I; Cole DE; Hendy GN
    Hum Mutat; 2009 Jan; 30(1):85-92. PubMed ID: 18712808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. R990G polymorphism of the calcium-sensing receptor and renal calcium excretion in patients with primary hyperparathyroidism.
    Corbetta S; Eller-Vainicher C; Filopanti M; Saeli P; Vezzoli G; Arcidiacono T; Loli P; Syren ML; Soldati L; Beck-Peccoz P; Spada A
    Eur J Endocrinol; 2006 Nov; 155(5):687-92. PubMed ID: 17062884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should the GCM2 gene be tested when screening for familial primary hyperparathyroidism?
    Coppin L; Dufosse M; Romanet P; Giraud S; North MO; Cardot Bauters C; Borson-Chazot F; Duchesne L; Métallo M; Lovecchio T; Barlier A; Odou MF
    Eur J Endocrinol; 2020 Jan; 182(1):57-65. PubMed ID: 31671402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial isolated primary hyperparathyroidism associated with germline GCM2 mutations is more aggressive and has a lesser rate of biochemical cure.
    El Lakis M; Nockel P; Guan B; Agarwal S; Welch J; Simonds WF; Marx S; Li Y; Nilubol N; Patel D; Yang L; Merkel R; Kebebew E
    Surgery; 2018 Jan; 163(1):31-34. PubMed ID: 29108698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the influence of the T393C polymorphism of the GNAS gene on the clinical expression of primary hyperparathyroidism.
    Piedra M; Berja A; Ramos L; García-Unzueta MT; Morán JM; Ruiz D; Amado JA
    Endocrinol Diabetes Nutr; 2017 Dec; 64(10):524-530. PubMed ID: 29179855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethnicity of Patients With Germline
    Guan B; Welch JM; Vemulapalli M; Li Y; Ling H; Kebebew E; Simonds WF; Marx SJ; Agarwal SK
    J Endocr Soc; 2017 May; 1(5):488-499. PubMed ID: 29264504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms at the regulatory regions of the CASR gene influence stone risk in primary hyperparathyroidism.
    Vezzoli G; Scillitani A; Corbetta S; Terranegra A; Dogliotti E; Guarnieri V; Arcidiacono T; Paloschi V; Rainone F; Eller-Vainicher C; Borghi L; Nouvenne A; Guerra A; Meschi T; Allegri F; Cusi D; Spada A; Cole DE; Hendy GN; Spotti D; Soldati L
    Eur J Endocrinol; 2011 Mar; 164(3):421-7. PubMed ID: 21183554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GCM2 Silencing in Parathyroid Adenoma Is Associated With Promoter Hypermethylation and Gain of Methylation on Histone 3.
    Singh P; Bhadada SK; Dahiya D; Saikia UN; Arya AK; Sachdeva N; Kaur J; Behera A; Brandi ML; Rao SD
    J Clin Endocrinol Metab; 2021 Sep; 106(10):e4084-e4096. PubMed ID: 34077544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Knock-In Mouse Model of the
    Parekh VI; Brinster LR; Guan B; Simonds WF; Weinstein LS; Agarwal SK
    J Endocr Soc; 2023 Oct; 7(11):bvad126. PubMed ID: 37885910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type I membrane klotho expression is decreased and inversely correlated to serum calcium in primary hyperparathyroidism.
    Björklund P; Krajisnik T; Akerström G; Westin G; Larsson TE
    J Clin Endocrinol Metab; 2008 Oct; 93(10):4152-7. PubMed ID: 18682507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variant Tyr 394Ser in the
    Tolkin L; Klein V; Frankel M; Altarescu G; Beeri R; Munter G
    J Endocr Soc; 2023 Jun; 7(7):bvad086. PubMed ID: 37362385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.